NDRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ENDRA Life Sciences Inc (NDRA) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock exhibits weak financial performance, no positive trading or news catalysts, and bearish technical indicators. Additionally, there are no Intellectia Proprietary Trading Signals to suggest a short-term opportunity.
The technical indicators for NDRA are bearish. The MACD is negatively expanding below 0, the RSI is at 37.133 (neutral zone), and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). Key support levels are at 3.062 and 2.892, with resistance at 3.612 and 3.782.
NULL. There are no significant news events, trading trends, or positive signals from Intellectia Proprietary Trading Signals.
Weak financial performance in Q3 2025, including a 32.20% YoY drop in net income and a 99.37% YoY drop in EPS. Bearish technical indicators and lack of trading trends from hedge funds or insiders further weigh against the stock.
In Q3 2025, NDRA reported zero revenue growth, a net income drop of -32.20% YoY, and a significant EPS decline of -99.37% YoY. Gross margin remained at 0%.
No analyst rating or price target changes available for NDRA.
